 Rheumatoid arthritis New developments treatment patient active rheumatoid arthritis significant relief nonsteroidal anti-inflammatory drugs prompt institution disease-modifying antirheumatic drugs DMARDs agent present hydroxychloroquine Plaquenil sulfate Careful follow-up essential DMARDs toxic effects severe unpredictable